Doctor profile · Federal record

Dr. Colin Edgerton, MD

Rheumatology Physician (CMS: Rheumatology) · Rheumatology Physician · Summerville, SC

  • NPI 1245307578
  • Accepts Medicare
  • MIPS 96.1 / 100 · 2023
  • 25 yrs in practice
  • Licensed in 2 states
  • Male
  • Solo practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
2001 2Nd Ave Ste 201
Summerville, SC 29486
(843) 572-4840
fax (843) 793-6156

Credentials & registration

NPPES · NUCC
NPI registered
November 2006 — 20 yrs on file
Profile last updated
September 13, 2022
Year of graduation
2001 — 25 yrs since
Specialty taxonomy
207RR0500X — NUCC code
State licenses (2)
South Carolina #35120 · Nebraska #22460

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1245307578. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
146,782
Distinct HCPCS
10
Medicare allowed
$2,405,543
HCPCS Description Services Patients Avg allowed
J3262 Injection, tocilizumab, 1 mg 40,318 32 $6
J1602 Injection, golimumab, 1 mg, for intravenous use 36,773 100 $13
J0717 Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) 23,000 19 $5
J0129 Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) 16,975 76 $42
J3111 Injection, romosozumab-aqqg, 1 mg 9,660 19 $10
J0490 Injection, belimumab, 10 mg 4,817 18 $37
Q5104 Injection, infliximab-abda, biosimilar, (renflexis), 10 mg 4,020 38 $37
J0897 Injection, denosumab, 1 mg 2,880 43 $23
J1745 Injection, infliximab, excludes biosimilar, 10 mg 2,490 25 $33
J9312 Injection, rituximab, 10 mg 1,700 11 $75

In context: peer comparison

Among 5 peers in Summerville Rheumatology Physician, average services per provider: 2,220. This provider delivers 66× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$1,510,483
Transactions
128
Manufacturers
15
Payer (manufacturer) Industry Txns Amount
American Rheumatology Network, LLC 1 $1,500,000.00
Sobi, INC 10 $6,177.45
Amgen INC. 26 $2,473.56
Abbvie INC. 28 $520.20
Janssen Biotech, INC. 17 $377.03
Ucb, INC. 13 $203.28
Novartis Pharmaceuticals Corporation 9 $178.13
Organon LLC 4 $98.60
Lilly USA, LLC 4 $83.30
AstraZeneca Pharmaceuticals Lp 4 $78.59
E.R. Squibb & Sons, L.L.C. 4 $68.01
Aurinia Pharma U.S., INC. 3 $64.62
Pfizer INC. 2 $45.97
GlaxoSmithKline, LLC. 2 $34.27
Kiniksa Pharmaceuticals International, Plc 1 $24.07

By nature of payment

Acquisitions
$1,500,000
Consulting Fee
$7,426
Food and Beverage
$2,742
Travel and Lodging
$315

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
936
Patients
361
Total drug cost
$195,627
Drug Type Claims Patients Total cost
Prednisone Generic 218 83 $1,828
Gabapentin Generic 100 38 $1,811
Hydroxychloroquine Sulfate Generic 94 45 $6,112
Celecoxib Generic 86 32 $2,982
Methotrexate (Methotrexate Sodium) Brand 79 39 $2,996
Allopurinol Generic 59 18 $561
Diclofenac Sodium Generic 48 23 $918
Duloxetine Hcl Generic 46 24 $1,433
Meloxicam Generic 46 24 $189
Nabumetone Generic 40 18 $883

Frequently asked questions

Auto-generated from federal data
What is Dr. Colin Edgerton's medical specialty?
Dr. Colin Edgerton practices Rheumatology Physician in Summerville, SC.
Where does Dr. Colin Edgerton practice?
Dr. Colin Edgerton practices at 2001 2Nd Ave Ste 201, Summerville, SC 29486. Office phone: 8435724840.
What is Dr. Colin Edgerton's NPI?
Dr. Colin Edgerton's National Provider Identifier (NPI) is 1245307578, issued by NPPES.
Does Dr. Colin Edgerton accept Medicare assignment?
Yes. Dr. Colin Edgerton accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Colin Edgerton commonly perform?
Top Medicare-reported procedures in 2023: Injection, tocilizumab, 1 mg (HCPCS J3262); Injection, golimumab, 1 mg, for intravenous use (HCPCS J1602); Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS J0717). Source: CMS Medicare Physician & Other Practitioners file.